₹606.25
▲ +1.63 +0.27%
30 Jul 2026
NSE Listed · Pharmaceuticals
Shilpa Medicare Ltd. (SHILPAMED)
Volume: 1,02,622Avg Vol 1W: 3,29,833Avg Vol 1M: 6,93,55852W Range:₹259.5₹650
Key Ratios
Checked just nowMarket Cap₹11,857 Cr
Current Price₹606.25
Previous Close₹604.62
High / Low (52w)₹650 / ₹259.5
Volume1,02,622
Avg Vol (1W)3,29,833
Avg Vol (1M)6,93,558
Stock P/E50.82
Book Value₹132.49
Dividend Yield10%
ROE9.39%
ROA6.57%
Revenue (TTM)—
Revenue Growth11.71%
Profit Margin15.81%
Total Debt₹232 Cr
Shares Outstanding20 Cr
Face Value₹1
EPS (TTM)₹11.93
P/B4.58
Debt / Equity0.36
50 DMA₹570.26
200 DMA₹406
Day change+0.27%
Price Chart
₹606.25▲ 31.91% · 1Y
2025-07-302026-07-30
20-day avg volume: 5.7L shares
Pros
- Pays a dividend yield of 10.0%.
- Company is almost debt-free.
- Revenue grew 21% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 51.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹293 Cr | ₹344 Cr | ₹319 Cr | ₹331 Cr | ₹321 Cr | ₹370 Cr | ₹410 Cr | ₹437 Cr |
| EBITDA | ₹56 Cr | ₹63 Cr | ₹53 Cr | ₹58 Cr | ₹69 Cr | ₹80 Cr | ₹85 Cr | ₹91 Cr |
| Net Profit | ₹14 Cr | ₹18 Cr | ₹32 Cr | ₹15 Cr | ₹47 Cr | ₹44 Cr | ₹45 Cr | ₹108 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹130 Cr | ₹125 Cr | ₹126 Cr | ₹1,310 Cr | ₹92 Cr | ₹135 Cr | ₹166 Cr | ₹201 Cr |
| EBITDA | ₹52 Cr | ₹27 Cr | ₹36 Cr | ₹227 Cr | ₹22 Cr | ₹43 Cr | ₹29 Cr | ₹52 Cr |
| Net Profit | ₹30 Cr | ₹16 Cr | ₹-6 Cr | ₹78 Cr | ₹21 Cr | ₹31 Cr | ₹16 Cr | ₹71 Cr |
| EPS | — | — | — | 8.04 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,499 Cr | ₹1,610 Cr | ₹1,989 Cr | ₹2,632 Cr | ₹2,875 Cr | ₹2,904 Cr | ₹3,093 Cr | ₹3,311 Cr |
| Total Liabilities | ₹419 Cr | ₹420 Cr | ₹668 Cr | ₹1,165 Cr | ₹1,064 Cr | ₹1,130 Cr | ₹1,293 Cr | ₹947 Cr |
| Equity | ₹1,080 Cr | ₹1,190 Cr | ₹1,321 Cr | ₹1,467 Cr | ₹1,811 Cr | ₹1,774 Cr | ₹1,800 Cr | ₹2,364 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹86 Cr | ₹183 Cr | ₹167 Cr | ₹95 Cr | ₹140 Cr | ₹212 Cr | ₹178 Cr | ₹179 Cr |
| Investing | ₹-9 Cr | ₹-196 Cr | ₹-290 Cr | ₹-404 Cr | ₹-285 Cr | ₹-233 Cr | ₹-167 Cr | ₹-199 Cr |
| Financing | ₹-61 Cr | ₹10 Cr | ₹176 Cr | ₹436 Cr | ₹83 Cr | ₹46 Cr | ₹47 Cr | ₹63 Cr |
| Free Cash Flow | ₹86 Cr | ₹183 Cr | ₹167 Cr | ₹95 Cr | ₹140 Cr | ₹212 Cr | ₹178 Cr | ₹179 Cr |
Shareholding
Promoter 40.13% Institutions 19.44% Public 40.43%
Efficiency & Working Capital
ROCE10.7%
Interest Coverage2.9
Dividend Payout—
Debtor Days125 d
Inventory Days99 d
Payable Days27 d
Cash Conversion Cycle197 d
Working Capital Days224 d
Shareholding Details
As of 2026-06-30
Promoter40.1%
FII11.4%
DII8.1%
Institutions19.4%
Public40.4%
Promoter Pledge8.7%
No. of Shareholders60,926
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2024 | Apr 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50% | 44.4% | 44.4% | 44.4% | 44.3% | 44.2% | 44.2% | 44.2% | 44.2% | 40.1% | 40.1% | 40.1% |
| FIIs | 5.7% | 9.7% | 9.7% | 9.1% | 9.6% | 9.9% | 11% | 11.2% | 10.9% | 11% | 11.1% | 11.4% |
| DIIs | 1.6% | 7.5% | 6.1% | 7.6% | 8.2% | 8.3% | 7.5% | 7.5% | 7.7% | 8.3% | 8.6% | 8.1% |
| Public | 42.7% | 38.4% | 39.8% | 38.9% | 37.9% | 37.6% | 37.3% | 37.1% | 37.2% | 40.6% | 40.2% | 40.4% |
| Promoter Pledge | 90.4% | 90.4% | 90.4% | 90.4% | 7.9% | 7.9% | 7.9% | 7.9% | 7.9% | 8.7% | 8.7% | 8.7% |
| No. of Shareholders | 44,793 | 44,809 | 44,809 | 41,072 | 42,784 | 49,034 | 50,108 | 48,636 | 52,065 | 53,799 | 53,410 | 60,926 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Vishnukant Chaturbhuj Bhutada | Shareholding of Promoter and Promoter Group | 6.5% | 1.27 Cr |
| Dharmavati Bhutada | Shareholding of Promoter and Promoter Group | 6.4% | 1.24 Cr |
| Ravi Kumar Innani | Shareholding of Promoter and Promoter Group | 4.1% | 80,12,740 |
| Suraj Kumar Inani | Public Shareholding | 4% | 78,41,390 |
| Om Prakash Inani | Shareholding of Promoter and Promoter Group | 2.9% | 57,35,382 |
| Deepak Kumar Innani | Shareholding of Promoter and Promoter Group | 2.8% | 54,67,920 |
| Kantadevi Inani | Shareholding of Promoter and Promoter Group | 2.6% | 50,80,192 |
| Sbi Life Insurance Co. Ltd | Public Shareholding | 2.3% | 45,27,562 |
| Sunidhi Capital Private Limited | Public Shareholding | 2.3% | 44,00,000 |
| Cohesion Mk Best Ideas Sub-trust | Public Shareholding | 2.2% | 42,52,274 |
| Keshav Bhutada | Shareholding of Promoter and Promoter Group | 2.1% | 40,00,000 |
| Madhav Vishnukant Bhutada | Shareholding of Promoter and Promoter Group | 2.1% | 40,00,000 |
| Amal Parikh | Public Shareholding | 1.7% | 33,81,156 |
| Dovetail India Fund Class 5 Shares | Public Shareholding | 1.7% | 33,37,132 |
| Ramakant Innani | Shareholding of Promoter and Promoter Group | 1.5% | 29,95,556 |
| Vishnukanth C Bhutada . | Shareholding of Promoter and Promoter Group | 1.4% | 26,72,260 |
| Taradevi Innani | Shareholding of Promoter and Promoter Group | 1.3% | 24,99,996 |
| Vishnukanta Inani | Shareholding of Promoter and Promoter Group | 1.2% | 24,24,996 |
| Bandhan Healthcare Fund | Public Shareholding | 1.2% | 24,31,840 |
| Brijgopal Innani | Shareholding of Promoter and Promoter Group | 1.2% | 23,49,732 |
| Elm Park Fund Limited | Public Shareholding | 1.2% | 23,00,000 |
| Icici Prudential Elss Tax Saver Fund | Public Shareholding | 1.2% | 22,90,936 |
| Natamal Innani | Shareholding of Promoter and Promoter Group | 1.2% | 22,62,464 |
| Shakuntalabai Innani | Shareholding of Promoter and Promoter Group | 1.2% | 22,58,372 |
| Sapphire Intrex Limited | Public Shareholding | 1.1% | 20,77,132 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Brijgopal Innani | 4,00,000 | 17% | 2026-06-30 |
| Om Prakash Inani | 4,00,000 | 7% | 2026-06-30 |
| Ramakant Innani | 13,50,000 | 45.1% | 2026-06-30 |
| Deepak Kumar Innani | 13,50,000 | 24.7% | 2026-06-30 |
| Vishnukant Chaturbhuj Bhutada | 20,00,000 | 15.7% | 2026-06-30 |
| Dharmavati Bhutada | 13,50,000 | 10.9% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Omprakash Inani | Chairman & Non Executive Dir. | 2025 |
| Vishnukant Bhutada | ED / MD / Promoter | 2025 |
| Hetal Gandhi | Independent Non Exe. Director | 2025 |
| Sharath Reddy Kalakota | E D & Wholetime Director | 2025 |
| Kamal K Sharma | Independent Non Exe. Director | 2025 |
| Anita Bandyopadhyay | Independent Non Exe. Director | 2025 |
| Ashraf Loutfy Abdelhamid Allam | Independent Non Exe. Director | 2025 |
| Keshav Bhutada | Executive Director & CEO | 2025 |
| Ritu Tiwary | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical product and services | ₹824 Cr | 99.3% |
| Power | ₹5 Cr | 0.6% |
| Others | ₹1 Cr | 0.1% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Within India | ₹319 Cr | 38.4% |
| Europe | ₹288 Cr | 34.7% |
| USA | ₹133 Cr | 16% |
| ROW | ₹91 Cr | 10.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 11 | 10 | 10 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| bonus | 2025-10-03 | 1:1 | 1:1 Bonus Issue of Equity Shares |
| dividend | 2025-09-17 | ₹1 (100%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 2,277 | 0 | 0 | 4 | 1 | 2,285 |
| 2025 | 2,046 | 0 | 0 | 0 | 0 | 2,046 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 1 |
Insider / Designated-Person Trades
30 recent disclosure(s)
PRIYA INANIDisposal · 1,00,000
VISHNUKANT CHATURBHUJ BHUTADAPledge · 10,00,000
OMPRAKASH INANIPledge · 2,00,000
DEEPAK KUMAR INNANIPledge · 6,75,000
DHARMAVATI BHUTADAPledge · 6,75,000
BRIJGOPAL INNANIPledge · 2,00,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Qualified Institutional Placement (qip)13/04/2024 · 1,09,89,010
Company Information
Incorporated1987
ChairmanOmprakash Inani
AuditorB N P S and Associates LLP
Investor Email[email protected]
📍 #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search